Democratic Republic of the Congo & International AIDS Vaccine Initiative

Democratic Republic of the Congo: The Democratic Republic of the Congo is the epicenter of the Ebola outbreak, with hundreds of confirmed cases and deaths. The country's health system is overwhelmed, and efforts to contain the virus are severely hindered by armed conflict, community mistrust, and a lack of resources.

International AIDS Vaccine Initiative: The International AIDS Vaccine Initiative is working on a modified version of the Zaire Ebola vaccine to fight the Bundibugyo strain, with experimental jabs showing nearly 100% protection in monkeys.

Democratic Republic of the Congo: The Democratic Republic of the Congo is experiencing an outbreak of Ebola Bundibugyo, with 282 confirmed cases and 42 deaths, making it the primary location for vaccine development and trials.

International AIDS Vaccine Initiative: The International AIDS Vaccine Initiative (IAVI) received an initial $3.2 million from CEPI to develop a single-dose Bundibugyo vaccine candidate using technology similar to Merck's Ervebo.

Democratic Republic of the Congo: The epicenter of the outbreak, facing a public health crisis with over 2,100 deaths and strained healthcare infrastructure. The government is coordinating the response but faces challenges from conflict and unpaid health workers.

International AIDS Vaccine Initiative: Developing a single-dose Bundibugyo vaccine candidate, which is being prioritized for clinical evaluation. Their work could provide an alternative vaccine.

Democratic Republic of the Congo: The Democratic Republic of the Congo is experiencing an ongoing outbreak of the Bundibugyo strain of Ebola, leading to the World Health Organization's recommendations for experimental treatments and vaccines.

International AIDS Vaccine Initiative: The International AIDS Vaccine Initiative is developing rVSV Bundibugyo, a single-dose vaccine candidate seen as promising by the World Health Organization, though it is not yet ready for trials.

Democratic Republic of the Congo: The Democratic Republic of the Congo>>> is the epicenter of the current Ebola outbreak, with hundreds of suspected cases and deaths, facing significant challenges in containment due to conflict, weak health infrastructure, and public mistrust.

International AIDS Vaccine Initiative: The International AIDS Vaccine Initiative is developing a Bundibugyo-specific version of a vaccine using a platform similar to Merck & Co.'s Ervebo vaccine, contributing to the search for a treatment.

Democratic Republic of the Congo: Epicenter of the outbreak; government struggling to contain spread amid conflict and mistrust; economic and social disruption.

International AIDS Vaccine Initiative: Partner in vaccine development efforts.